Who
Jason Hannon
Director
Company insider
Files Form 4 as: Director, Orthofix Medical; President and COO, Nuvasive.
In numbers
- Trades disclosed
- 267
- Buys
- 0
- Sells
- 65
- Bought
- $0
- Sold
- $13.7M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 3 Jan 2006
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —18,841 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | $195K15,152 at $12.87 | filing |
| 5 Jan 2023filed 9 Feb 2023 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,354 at $0.00 | filing |
| 5 Jan 2023filed 9 Jan 2023 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,052 at $0.00 | filing |
| 6 Jun 2022filed 8 Jun 2022 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —6,383 at $0.00 | filing |
| 21 Jun 2021filed 23 Jun 2021 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —4,313 at $0.00 | filing |
| 8 Jun 2020filed 10 Jun 2020 | OFIX Orthofix Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —24,701 at $0.00 | filing |
| 8 Jun 2020filed 10 Jun 2020 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —4,588 at $0.00 | filing |
| 8 Mar 2017filed 9 Mar 2017 | Nuvasive | SEC FORM 4 Sold | $1.8M24,340 at $74.21 | filing |
| 8 Mar 2017filed 9 Mar 2017 | Nuvasive | SEC FORM 4 Sold | $37K500 at $74.80 | filing |
| 7 Mar 2017filed 9 Mar 2017 | Nuvasive | SEC FORM 4 Code M | $3.4M97,375 at $34.82 | filing |
| 7 Mar 2017filed 9 Mar 2017 | Nuvasive | SEC FORM 4 Code F | $5.4M72,535 at $74.63 | filing |
| 7 Mar 2017filed 9 Mar 2017 | Nuvasiveoption or derivative | SEC FORM 4 Code M | —97,375 at $0.00 | filing |
| 8 Feb 2017filed 10 Feb 2017 | Nuvasiveoption or derivative | SEC FORM 4 Code A | —13,203 at $0.00 | filing |
| 1 Feb 2017filed 3 Feb 2017 | Nuvasive | SEC FORM 4 Code M | —4,397 at $0.00 | filing |
| 1 Feb 2017filed 3 Feb 2017 | Nuvasive | SEC FORM 4 Code M | —12,375 at $0.00 | filing |
| 1 Feb 2017filed 3 Feb 2017 | Nuvasive | SEC FORM 4 Code M | —2,660 at $0.00 | filing |
| 1 Feb 2017filed 3 Feb 2017 | Nuvasive | SEC FORM 4 Code F | $697K9,856 at $70.76 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.